8189 — Tianjin Teda Biomedical Engineering Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$458.81m
- HK$540.62m
- CNY522.97m
Annual cashflow statement for Tianjin Teda Biomedical Engineering Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -44.8 | -26.5 | -17.6 | -38.2 | -113 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 39.4 | 4.93 | 2.77 | 24.9 | 123 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -10.7 | -6.64 | -9.95 | -22.1 | -74.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.68 | -12.8 | -13.2 | -26.3 | -54.6 |
| Capital Expenditures | -27.6 | -8.8 | -2.47 | -2.56 | -8.26 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 19.1 | -4.13 | 2 | -34.7 | 39.6 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -8.51 | -12.9 | -0.467 | -37.2 | 31.4 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 28.1 | 6.17 | 12.7 | 83 | 27 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 12.9 | -19.6 | -0.893 | 19.4 | 3.81 |